Business · 16/11/1998
FDA Announces Amendment to Oncologic Drugs Advisory Committee Meeting Notice
The FDA is canceling a session of the Oncologic Drugs Advisory Committee meeting originally scheduled for November 17, 1998, as part of an amendment to the meeting notice announced on October 29, 1998
Original source language: Federal Register — Food and Drug AdministrationOpen original release →